ERYTECH Pharma S.A. ERYP.PA Stock
ERYTECH Pharma S.A. Price Chart
ERYTECH Pharma S.A. ERYP.PA Financial and Trading Overview
| ERYTECH Pharma S.A. stock price | 0.84 EUR |
| Previous Close | 0.82 EUR |
| Open | 0.85 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0.82 - 0.85 EUR |
| 52 Week Range | 0.29 - 1.48 EUR |
| Volume | 20.77K EUR |
| Avg. Volume | 261.87K EUR |
| Market Cap | 29.37M EUR |
| Beta (5Y Monthly) | 2.129118 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ERYP.PA Valuation Measures
| Enterprise Value | -719318 EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.8127451 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.4189677 |
| Price/Book (mrq) | 1.0951122 |
| Enterprise Value/Revenue | -0.108 |
| Enterprise Value/EBITDA | 0.029 |
Trading Information
ERYTECH Pharma S.A. Stock Price History
| Beta (5Y Monthly) | 2.129118 |
| 52-Week Change | -20.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.48 EUR |
| 52 Week Low | 0.29 EUR |
| 50-Day Moving Average | 0.88 EUR |
| 200-Day Moving Average | 0.75 EUR |
ERYP.PA Share Statistics
| Avg. Volume (3 month) | 261.87K EUR |
| Avg. Daily Volume (10-Days) | 109.5K EUR |
| Shares Outstanding | 34.12M |
| Float | 27.99M |
| Short Ratio | N/A |
| % Held by Insiders | 6.59% |
| % Held by Institutions | 11.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -3.42% |
| Operating Margin (ttm) | -408.41% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.14% |
| Return on Equity (ttm) | -0.98% |
Income Statement
| Revenue (ttm) | 6.65M EUR |
| Revenue Per Share (ttm) | 0.21 EUR |
| Quarterly Revenue Growth (yoy) | 571.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -24972000 EUR |
| Net Income Avi to Common (ttm) | -228000 EUR |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 38.79M EUR |
| Total Cash Per Share (mrq) | 1.25 EUR |
| Total Debt (mrq) | 13.57M EUR |
| Total Debt/Equity (mrq) | 57.76 EUR |
| Current Ratio (mrq) | 3.651 |
| Book Value Per Share (mrq) | 0.757 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31764000 EUR |
| Levered Free Cash Flow (ttm) | -21078250 EUR |
Profile of ERYTECH Pharma S.A.
| Country | France |
| State | N/A |
| City | Lyon |
| Address | 60 Avenue Rockefeller |
| ZIP | 69008 |
| Phone | 33 4 78 74 44 38 |
| Website | https://www.erytech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 49 |
ERYTECH Pharma S.A., a biopharmaceutical company, focus on development of red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. ERYTECH Pharma S.A. was incorporated in 2004 and is headquartered in Lyon, France.
Q&A For ERYTECH Pharma S.A. Stock
What is a current ERYP.PA stock price?
ERYTECH Pharma S.A. ERYP.PA stock price today per share is 0.84 EUR.
How to purchase ERYTECH Pharma S.A. stock?
You can buy ERYP.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ERYTECH Pharma S.A.?
The stock symbol or ticker of ERYTECH Pharma S.A. is ERYP.PA.
Which industry does the ERYTECH Pharma S.A. company belong to?
The ERYTECH Pharma S.A. industry is Biotechnology.
How many shares does ERYTECH Pharma S.A. have in circulation?
The max supply of ERYTECH Pharma S.A. shares is 35.43M.
What is ERYTECH Pharma S.A. Price to Earnings Ratio (PE Ratio)?
ERYTECH Pharma S.A. PE Ratio is 0.00000000 now.
What was ERYTECH Pharma S.A. earnings per share over the trailing 12 months (TTM)?
ERYTECH Pharma S.A. EPS is 0 EUR over the trailing 12 months.
Which sector does the ERYTECH Pharma S.A. company belong to?
The ERYTECH Pharma S.A. sector is Healthcare.
ERYTECH Pharma S.A. ERYP.PA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| CAC Mid & Small MS190 | 14267.59 EUR 15596.4 USD |
-0.38
|
— — | — — | — — | — - | — — |
| CAC Small CS90 | 11739.13 EUR 12832.46 USD |
-0.74
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}